ArticleOncotarget2016

Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.

Heba Alshaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.